| Aug 12 |
Unveiling 6 Analyst Insights On Kymera Therapeutics
|
| Aug 10 |
Kymera Therapeutics, Inc. (KYMR) Q2 2024 Earnings Call Transcript
|
| Aug 10 |
Earnings Beat: Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
|
| Aug 8 |
Kymera (KYMR) Q2 Loss Narrower Than Expected, Pipeline in Focus
|
| Aug 8 |
Kymera Therapeutics Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 7 |
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 7 |
Kymera Therapeutics GAAP EPS of -$0.58 beats by $0.12, revenue of $25.7M beats by $13.15M
|
| Aug 7 |
Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
|
| Jul 31 |
Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7
|
| Jul 25 |
We're Not Worried About Kymera Therapeutics' (NASDAQ:KYMR) Cash Burn
|
